NGVT vs. ALTM, CSWI, AVNT, MEOH, CC, BAK, PRM, PCT, UAN, and TROX
Should you be buying Ingevity stock or one of its competitors? The main competitors of Ingevity include Arcadium Lithium (ALTM), CSW Industrials (CSWI), Avient (AVNT), Methanex (MEOH), Chemours (CC), Braskem (BAK), Perimeter Solutions (PRM), PureCycle Technologies (PCT), CVR Partners (UAN), and Tronox (TROX). These companies are all part of the "chemicals" industry.
Ingevity vs.
Ingevity (NYSE:NGVT) and Arcadium Lithium (NYSE:ALTM) are both basic materials companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations, community ranking and institutional ownership.
Ingevity currently has a consensus target price of $55.17, indicating a potential upside of 27.70%. Arcadium Lithium has a consensus target price of $11.00, indicating a potential upside of 88.20%. Given Arcadium Lithium's higher probable upside, analysts clearly believe Arcadium Lithium is more favorable than Ingevity.
Ingevity received 378 more outperform votes than Arcadium Lithium when rated by MarketBeat users. Likewise, 64.96% of users gave Ingevity an outperform vote while only 15.38% of users gave Arcadium Lithium an outperform vote.
Ingevity has a beta of 1.53, meaning that its share price is 53% more volatile than the S&P 500. Comparatively, Arcadium Lithium has a beta of 1.48, meaning that its share price is 48% more volatile than the S&P 500.
In the previous week, Ingevity had 8 more articles in the media than Arcadium Lithium. MarketBeat recorded 8 mentions for Ingevity and 0 mentions for Arcadium Lithium. Ingevity's average media sentiment score of 1.01 beat Arcadium Lithium's score of 0.00 indicating that Ingevity is being referred to more favorably in the media.
Arcadium Lithium has a net margin of 0.00% compared to Ingevity's net margin of -30.60%. Ingevity's return on equity of 41.44% beat Arcadium Lithium's return on equity.
91.6% of Ingevity shares are held by institutional investors. Comparatively, 27.0% of Arcadium Lithium shares are held by institutional investors. 1.1% of Ingevity shares are held by company insiders. Comparatively, 0.4% of Arcadium Lithium shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Arcadium Lithium has lower revenue, but higher earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than Arcadium Lithium, indicating that it is currently the more affordable of the two stocks.
Summary
Ingevity beats Arcadium Lithium on 12 of the 18 factors compared between the two stocks.
Get Ingevity News Delivered to You Automatically
Sign up to receive the latest news and ratings for NGVT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Ingevity Competitors List
Related Companies and Tools
This page (NYSE:NGVT) was last updated on 3/24/2025 by MarketBeat.com Staff
Buy NGVT Stock Free NGVT Stock Alerts